Represents the contractual benefit under the letter agreement in order to exercise hedge transactions in connection with the merger.

Name:	ceph_ContractualBenefitOfAgreementInConnectionWithMerger
Namespace Prefix:	ceph
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	ceph_ForeignExchangeContractsLineItems
Namespace Prefix:	ceph
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Decrease in the fair value of the derivative or group of derivatives included in earnings in the period.

+ References

+ Details

Name:	us-gaap_DerivativeLossOnDerivative
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate foreign currency transaction gain (loss) (both realized and unrealized) included in determining net income for the reporting period. Excludes foreign currency transactions designated as hedges of net investment in a foreign entity and intercompany foreign currency transactions that are of a long-term nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements. For certain enterprises, primarily banks, that are dealers in foreign exchange, foreign currency transaction gains (losses) may be disclosed as dealer gains (losses).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 52
-Paragraph 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

+ Details

Name:	us-gaap_ForeignCurrencyTransactionGainLossBeforeTax
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Aggregate impact of foreign currency derivatives on earnings for the period. Includes impact of foreign currency cash flow hedge ineffectiveness and the ineffectiveness of fair value hedging derivatives and full change in fair value of the foreign currency derivatives not designated as hedging instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624177-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624171-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

+ Details

Name:	us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_OtherIncomeAndExpensesAbstract
Namespace Prefix:	us-gaap
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 03
-Paragraph 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name:	us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

OTHER INCOME (EXPENSE), NET (Details) (USD $)	3 Months Ended		6 Months Ended
OTHER INCOME (EXPENSE), NET (Details) (USD $)	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
OTHER INCOME (EXPENSE), NET
Loss on letter agreement derivative instrument	$ (22,078,000)		$ (22,078,000)
Gains (losses) on foreign exchange derivative instruments	5,595,000	(2,900,000)	5,089,000	(9,069,000)
Foreign exchange gains (losses)	(9,877,000)	(6,432,000)	(12,399,000)	(7,534,000)
Other income (expense), net	(26,360,000)	(9,332,000)	(29,388,000)	(16,603,000)
Foreign exchange contracts
Gain (loss) from the increase (decrease) in fair value of foreign exchange contracts	5,595,000	(2,900,000)	5,089,000	(9,069,000)
ChemGenex Pharmaceuticals Limited
OTHER INCOME (EXPENSE), NET
Gains (losses) on foreign exchange derivative instruments	5,600,000		5,600,000
Foreign exchange contracts
Gain (loss) from the increase (decrease) in fair value of foreign exchange contracts	5,600,000		5,600,000
Mesoblast Limited
OTHER INCOME (EXPENSE), NET
Gains (losses) on foreign exchange derivative instruments			(500,000)
Foreign exchange contracts
Gain (loss) from the increase (decrease) in fair value of foreign exchange contracts			(500,000)
Mepha GmbH
OTHER INCOME (EXPENSE), NET
Gains (losses) on foreign exchange derivative instruments		(2,900,000)		(9,100,000)
Foreign exchange contracts
Gain (loss) from the increase (decrease) in fair value of foreign exchange contracts		(2,900,000)		(9,100,000)
The DB Group
Foreign exchange contracts
Contractual benefit of agreement in connection with merger			$ 151,800,000